Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV (2021)
Attributed to:
Pathogen Genomics, Phenotype and Immunity (PGPI) & Basic Sciences Programme
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2101609
PubMed Identifier: 34289276
Publication URI: http://europepmc.org/abstract/MED/34289276
Type: Journal Article/Review
Parent Publication: New England Journal of Medicine
Issue: 4
ISSN: 0028-4793